X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-01-05 | ARWR | O'Brien Patrick | COO | S - Sale | $63.11 | -49,493 | 474,908 | -9% | -$3,123,349 | ||||||
2026-01-05 | ARWR | Hamilton James C | Chief Medical Officer | S - Sale | $63.11 | -40,164 | 171,958 | -19% | -$2,534,661 | ||||||
2026-01-02 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $66.10 | -13,187 | 3,792,739 | 0% | -$871,703 | ||||||
| D | 2025-12-29 | ARWR | Anzalone Christopher Richard | CEO | S - Sale+OE | $69.13 | -51,726 | 3,805,926 | -1% | -$3,575,575 | |||||
2025-12-26 | ARWR | Ferrari Mauro | Dir | S - Sale | $70.00 | -7,530 | 69,053 | -10% | -$527,100 | ||||||
2025-12-19 | ARWR | Waddill William D. | Dir | S - Sale | $67.65 | -8,367 | 56,563 | -13% | -$566,038 | ||||||
2025-12-19 | ARWR | Vakiener Victoria | Dir | S - Sale | $67.68 | -10,040 | 35,723 | -22% | -$679,491 | ||||||
| M | 2025-12-19 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $68.04 | -26,031 | 3,805,926 | -1% | -$1,771,022 | |||||
2025-12-19 | ARWR | Olukotun Adeoye Y | Dir | S - Sale | $67.66 | -10,000 | 33,600 | -23% | -$676,623 | ||||||
2025-12-17 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $64.04 | -85,000 | 3,831,957 | -2% | -$5,443,462 | ||||||
| M | 2025-12-15 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $67.00 | -184,298 | 3,916,957 | -4% | -$12,348,802 | |||||
2025-12-05 | ARWR | Perry Michael S | Dir | S - Sale | $61.03 | -16,250 | 115,240 | -12% | -$991,738 | ||||||
2025-11-28 | ARWR | Ferrari Mauro | Dir | S - Sale | $56.39 | -8,750 | 68,764 | -11% | -$493,413 | ||||||
2025-10-01 | ARWR | Hamilton James C | Chief Medical Officer | S - Sale | $35.00 | -20,000 | 212,122 | -9% | -$700,000 | ||||||
2025-09-12 | ARWR | Hamilton James C | Chief Medical Officer | S - Sale | $30.00 | -15,000 | 232,122 | -6% | -$450,000 | ||||||
2025-09-02 | ARWR | Hamilton James C | Chief Medical Officer | S - Sale | $25.00 | -15,000 | 247,122 | -6% | -$375,000 | ||||||
| M | 2025-08-13 | ARWR | Hamilton James C | Chief Medical Officer | S - Sale | $20.00 | -10,000 | 262,122 | -4% | -$200,000 | |||||
| M | 2025-04-09 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $10.87 | -141,122 | 3,921,255 | -3% | -$1,533,337 | |||||
2025-03-13 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $15.07 | -51,425 | 4,062,377 | -1% | -$774,975 | ||||||
| DM | 2025-03-03 | ARWR | Anzalone Christopher Richard | CEO | S - Sale+OE | $17.58 | -300,000 | 3,773,802 | -7% | -$5,274,334 | |||||
2025-01-23 | ARWR | Olukotun Adeoye Y | Dir | S - Sale | $21.00 | -959 | 35,781 | -3% | -$20,139 | ||||||
2025-01-06 | ARWR | Hamilton James C | Chief Discovery, Trans Medicin | S - Sale | $19.82 | -32,729 | 272,122 | -11% | -$648,824 | ||||||
| M | 2025-01-06 | ARWR | O'Brien Patrick | COO, GC | S - Sale | $19.80 | -37,184 | 527,201 | -7% | -$736,059 | |||||
| M | 2025-01-06 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale | $19.77 | -45,167 | 455,433 | -9% | -$893,095 | |||||
2025-01-02 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $19.05 | -11,520 | 3,764,252 | 0% | -$219,456 | ||||||
2024-12-27 | ARWR | Olukotun Adeoye Y | Dir | S - Sale | $20.00 | -2,850 | 36,740 | -7% | -$57,000 | ||||||
2024-12-23 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $19.59 | -12,563 | 3,775,772 | 0% | -$246,109 | ||||||
2024-12-18 | ARWR | Anzalone Christopher Richard | CEO | S - Sale | $21.24 | -26,712 | 3,788,335 | -1% | -$567,486 | ||||||
| M | 2024-12-16 | ARWR | Waddill William D. | Dir | S - Sale | $21.97 | -7,495 | 40,378 | -16% | -$164,665 | |||||
| M | 2024-12-16 | ARWR | Given Douglas B | Dir | S - Sale | $21.91 | -5,547 | 124,167 | -4% | -$121,556 | |||||
2024-12-16 | ARWR | Vakiener Victoria | Dir | S - Sale | $21.91 | -8,994 | 21,211 | -30% | -$197,059 | ||||||
2024-07-02 | ARWR | Oliver Tracie | Chief Commercial Officer | S - Sale | $25.28 | -9,394 | 127,107 | -7% | -$237,480 | ||||||
2024-05-02 | ARWR | Vakiener Victoria | Dir | S - Sale | $23.31 | -1,799 | 30,205 | -6% | -$41,935 | ||||||
2024-04-01 | ARWR | Hamilton James C | Chief Discovery, Trans Medicin | S - Sale | $28.03 | -6,000 | 204,851 | -3% | -$168,180 | ||||||
| M | 2024-03-18 | ARWR | Lu Hongbo | Dir | P - Purchase | $27.66 | +3,000 | 33,680 | +10% | +$82,990 | |||||
2024-03-06 | ARWR | Myszkowski Kenneth Allen | CFO | S - Sale | $35.19 | -40,000 | 400,600 | -9% | -$1,407,600 | ||||||
| D | 2024-01-31 | ARWR | Anzalone Christopher Richard | CEO | S - Sale+OE | $32.35 | -57,499 | 3,715,048 | -2% | -$1,860,019 | |||||
2024-01-12 | ARWR | Hamilton James C | Chief Discovery, Trans Medicin | S - Sale | $36.89 | -7,940 | 210,851 | -4% | -$292,904 | ||||||
2024-01-11 | ARWR | Given Douglas B | Dir | S - Sale | $38.06 | -2,911 | 129,711 | -2% | -$110,788 | ||||||
2024-01-11 | ARWR | Waddill William D. | Dir | S - Sale | $38.07 | -3,934 | 47,870 | -8% | -$149,759 | ||||||
2024-01-11 | ARWR | Ferrari Mauro | Dir | S - Sale | $38.06 | -3,147 | 60,778 | -5% | -$119,787 | ||||||
2024-01-11 | ARWR | Vakiener Victoria | Dir | S - Sale | $38.10 | -4,720 | 32,001 | -13% | -$179,813 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |